STRATA Skin Sciences (SSKN) Net Cash Flow Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.50% |
| Sep 30, 2025 | 53.81% |
| Jun 30, 2025 | -43.14% |
| Mar 31, 2025 | -227.46% |
| Dec 31, 2024 | 18.46% |
| Sep 30, 2024 | 40.64% |
| Jun 30, 2024 | 20.58% |
| Mar 31, 2024 | -73.64% |
| Dec 31, 2023 | -20.86% |
| Sep 30, 2023 | -27.26% |
| Jun 30, 2023 | -10.85% |
| Mar 31, 2023 | -31.96% |
| Dec 31, 2022 | -32.86% |
| Sep 30, 2022 | -8.53% |
| Jun 30, 2022 | -47.87% |
| Mar 31, 2022 | -58.74% |
| Dec 31, 2021 | -19.87% |
| Sep 30, 2021 | -104.19% |
| Jun 30, 2021 | -11.46% |
| Mar 31, 2021 | -26.25% |
| Dec 31, 2020 | -34.69% |
| Sep 30, 2020 | 41.24% |
| Jun 30, 2020 | 16.81% |
| Mar 31, 2020 | 14.88% |
| Dec 31, 2019 | 27.70% |
| Sep 30, 2019 | -51.10% |
| Jun 30, 2019 | 35.20% |
| Mar 31, 2019 | -15.13% |
| Dec 31, 2018 | -12.42% |
| Sep 30, 2018 | 16.16% |
| Jun 30, 2018 | 29.90% |
| Mar 31, 2018 | -15.41% |
| Dec 31, 2017 | 16.81% |
| Sep 30, 2017 | 27.09% |
| Jun 30, 2017 | 15.26% |
| Mar 31, 2017 | 50.75% |
| Dec 31, 2016 | 17.51% |
| Sep 30, 2016 | 15.21% |
| Jun 30, 2016 | 43.79% |
| Mar 31, 2016 | 47.25% |
| Dec 31, 2015 | 15.18% |
| Sep 30, 2015 | -17.40% |